Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study).

Young, Elisa J; Tabrizi, Sepehr N; Brotherton, Julia Ml; Wark, John D; Pyman, Jan; Saville, Marion; Wrede, C David; Jayasinghe, Yasmin; Tan, Jeffrey; Gertig, Dorota M; Pitts, Marian; Garland, Suzanne M

Young, Elisa J; Tabrizi, Sepehr N; Brotherton, Julia Ml; Wark, John D; Pyman, Jan; Saville, Marion; Wrede, C David; Jayasinghe, Yasmin; Tan, Jeffrey; Gertig, Dorota M; Pitts, Marian; Garland, Suzanne M.

Affiliation

Young EJ; Department of Microbiology and Infectious Diseases, Royal Women's Hospital, Parkville, Melbourne, VIC 3052, Australia.

BMC Cancer ; 13: 296, 2013 Jun 19.

Article in En | MEDLINE | ID: mdl-23777549

Subject(s)

Papillomaviridae/genetics; Papillomavirus Infections/prevention & control; Papillomavirus Vaccines/therapeutic use; Uterine Cervical Dysplasia/prevention & control; Uterine Cervical Dysplasia/virology; Uterine Cervical Neoplasms/prevention & control; Uterine Cervical Neoplasms/virology; Adolescent; Adult; Australia; Female; Genotype; Humans; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Papillomaviridae / Uterine Cervical Dysplasia / Uterine Cervical Neoplasms / Papillomavirus Infections / Papillomavirus Vaccines Type of study: Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans Country/Region as subject: Oceania Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2013 Type: Article Affiliation country: Australia

Fulltext

XML

PubMed Links

Search on Google